SELLAS Life Sciences (SLS) Operating Margin Growth (1y) (2013 - 2022)
SELLAS Life Sciences (SLS) Operating Margin Growth (1y) (2013 - 2022) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Operating Margin Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
3,609.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
1,536.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
SELLAS Life Sciences |
1.39 Bn |
1.39 Bn |
- |
- |
| Date | Value |
|---|
| Mar 31, 2022 |
-163,411.00 |
| Jun 30, 2015 |
40,852.00 |
| Mar 31, 2015 |
22,121.00 |
| Dec 31, 2014 |
-8,432.00 |
| Sep 30, 2014 |
-22,679.00 |
| Jun 30, 2014 |
-33,449.00 |
| Mar 31, 2014 |
-24,105.00 |
| Dec 31, 2013 |
-69,581.00 |
| Sep 30, 2013 |
4,698.00 |
